GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Navco Pharmaceuticals Inc (FRA:F0U) » Definitions » Operating Margin %

Navco Pharmaceuticals (FRA:F0U) Operating Margin % : 0.00% (As of Mar. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Navco Pharmaceuticals Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Navco Pharmaceuticals's Operating Income for the six months ended in Mar. 2023 was €0.01 Mil. Navco Pharmaceuticals's Revenue for the six months ended in Mar. 2023 was €0.00 Mil. Therefore, Navco Pharmaceuticals's Operating Margin % for the quarter that ended in Mar. 2023 was 0.00%.

The historical rank and industry rank for Navco Pharmaceuticals's Operating Margin % or its related term are showing as below:


FRA:F0U's Operating Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 6.615
* Ranked among companies with meaningful Operating Margin % only.

Navco Pharmaceuticals's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Navco Pharmaceuticals's Operating Income for the six months ended in Mar. 2023 was €0.01 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2023 was €-0.05 Mil.


Navco Pharmaceuticals Operating Margin % Historical Data

The historical data trend for Navco Pharmaceuticals's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Navco Pharmaceuticals Operating Margin % Chart

Navco Pharmaceuticals Annual Data
Trend Jun18 Jun19 Jun20 Jun21
Operating Margin %
- - - -

Navco Pharmaceuticals Semi-Annual Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Navco Pharmaceuticals's Operating Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Navco Pharmaceuticals's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Navco Pharmaceuticals's Operating Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Navco Pharmaceuticals's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Navco Pharmaceuticals's Operating Margin % falls into.



Navco Pharmaceuticals Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Navco Pharmaceuticals's Operating Margin % for the fiscal year that ended in Jun. 2021 is calculated as

Operating Margin %=Operating Income (A: Jun. 2021 ) / Revenue (A: Jun. 2021 )
=-0.08 / 0
= %

Navco Pharmaceuticals's Operating Margin % for the quarter that ended in Mar. 2023 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2023 ) / Revenue (Q: Mar. 2023 )
=0.007 / 0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Navco Pharmaceuticals  (FRA:F0U) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Navco Pharmaceuticals Operating Margin % Related Terms

Thank you for viewing the detailed overview of Navco Pharmaceuticals's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Navco Pharmaceuticals Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
1055 West Georgia Street, Suite 1500, Vancouver, BC, CAN, V6E 4N7
Navco Pharmaceuticals Inc uses nanotechnology to develop and commercialize novel products to protect against viruses, bacteria, and infectious diseases. Its products have applications in the medical, personal care products, textile, chemical, and additive industries which are tailored to defend against microorganisms such as viruses, bacteria, fungi, and infectious diseases.

Navco Pharmaceuticals Headlines

No Headlines